Authors:
Nagai, K
Davies, TA
Dewasse, BE
Jacobs, MR
Appelbaum, PC
Citation: K. Nagai et al., Single- and multi-step resistance selection study of gemifloxacin comparedwith trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae, J ANTIMICRO, 48(3), 2001, pp. 365-374
Authors:
Nagai, K
Davies, TA
Ednie, LM
Bryskier, A
Palavecino, E
Jacobs, MR
Appelbaum, PC
Citation: K. Nagai et al., Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S-pyogenes, ANTIM AG CH, 45(11), 2001, pp. 3242-3245
Authors:
Syrogiannopoulos, GA
Grivea, IN
Tait-Kamradt, A
Katopodis, GD
Beratis, NG
Sutcliffe, J
Appelbaum, PC
Davies, TA
Citation: Ga. Syrogiannopoulos et al., Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece, ANTIM AG CH, 45(1), 2001, pp. 342-344
Authors:
Syrogiannopoulos, GA
Grivea, IN
Davies, TA
Katopodis, GD
Appelbaum, PC
Beratis, NG
Citation: Ga. Syrogiannopoulos et al., Antimicrobial use and colonization with erythromycin-resistant Streptococcus pnemoniae in Greece during the first 2 years of life, CLIN INF D, 31(4), 2000, pp. 887-893
Authors:
Syrogiannopoulos, GA
Ronchetti, F
Dagan, R
Grivea, I
Ronchetti, MP
Porat, N
Davies, TA
Ronchetti, R
Appelbaum, PC
Jacobs, MR
Citation: Ga. Syrogiannopoulos et al., Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel, INT J ANT A, 16(3), 2000, pp. 219-224
Authors:
Eisenhauer, PB
Johnson, RJ
Wells, JM
Davies, TA
Fine, RE
Citation: Pb. Eisenhauer et al., Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: Increased toxicity of Dutch-type mutant, J NEUROSC R, 60(6), 2000, pp. 804-810
Authors:
Nagai, K
Davies, TA
Dewasse, BE
Pankuch, GA
Jacobs, MR
Appelbaum, PC
Citation: K. Nagai et al., In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae, J ANTIMICRO, 46(6), 2000, pp. 909-915
Authors:
Davies, TA
Kelly, LM
Jacobs, MR
Appelbaum, PC
Citation: Ta. Davies et al., Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies, J CLIN MICR, 38(4), 2000, pp. 1444-1448
Authors:
Davies, TA
Kelly, LM
Hoellman, DB
Ednie, LM
Clark, CL
Bajaksouzian, S
Jacobs, MR
Appelbaum, PC
Citation: Ta. Davies et al., Activities and postantibiotic effects of gemifloxacin compared to those of11 other agents against Haemophilus influenzae and Moraxella catarrhalis, ANTIM AG CH, 44(3), 2000, pp. 633-639
Citation: Ta. Davies et al., In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae, ANTIM AG CH, 44(2), 2000, pp. 414-417
Authors:
Nagai, K
Davies, TA
Pankuch, GA
Dewasse, BE
Jacobs, MR
Appelbaum, PC
Citation: K. Nagai et al., In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae, ANTIM AG CH, 44(10), 2000, pp. 2740-2746
Authors:
Davies, TA
Pankuch, GA
Dewasse, BE
Jacobs, MR
Appelbaum, PC
Citation: Ta. Davies et al., In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae, ANTIM AG CH, 43(5), 1999, pp. 1177-1182